Investment Thesis
Exact Sciences Corporation (EXAS) and DexCom, Inc. (DXCM) are active investment alternatives in competition with dozens of other medical diagnostic and research enterprises. Success from an investment point of view relates more to increased stock price than lives saved.
That measure depends importantly on a combination of research capability and reputation, medical competitive marketing skills, and comparative forecasts of well-informed securities markets pros. The end result of stock price competitions between alternative investments often is greatly conditioned by market circumstances including the varied investment appetites of huge-money institutional portfolio managers.
At